These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38155377)

  • 41. Choriocarcinoma following a partial hydatidiform mole: a case report.
    Gardner HA; Lage JM
    Hum Pathol; 1992 Apr; 23(4):468-71. PubMed ID: 1563750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mismatch repair gene promoter methylation and expression in hydatidiform moles.
    Chen H; Ye D; Xie X; Lu W; Zhu C; Chen X
    Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
    Dong Y; Zhang S; Wang ML; Guo H; Zhang Y; Wang Y; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):194-8. PubMed ID: 21503111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Telomerase activity in complete hydatidiform mole.
    Bae SN; Kim SJ
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):328-33. PubMed ID: 9988795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of TGF-beta signaling proteins in normal placenta and gestational trophoblastic disease.
    Xuan YH; Choi YL; Shin YK; Ahn GH; Kim KH; Kim WJ; Lee HC; Kim SH
    Histol Histopathol; 2007 Mar; 22(3):227-34. PubMed ID: 17163397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysregulation of Placental Functions and Immune Pathways in Complete Hydatidiform Moles.
    King JR; Wilson ML; Hetey S; Kiraly P; Matsuo K; Castaneda AV; Toth E; Krenacs T; Hupuczi P; Mhawech-Fauceglia P; Balogh A; Szilagyi A; Matko J; Papp Z; Roman LD; Cortessis VK; Than NG
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma.
    Collet C; Lopez J; Battail C; Allias F; Devouassoux-Shisheboran M; Patrier S; Lemaitre N; Hajri T; Massardier J; You B; Mallet F; Golfier F; Alfaidy N; Bolze PA
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The changes of gene expression profiles in hydatidiform mole and choriocarcinoma with hyperplasia of trophoblasts.
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Int J Gynecol Cancer; 2004; 14(5):984-97. PubMed ID: 15361213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
    Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53 expression in placentas with hydropic change and hydatidiform moles.
    Cheville JC; Robinson RA; Benda JA
    Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human epidermal growth factor receptor 2 fluorescence in situ hybridization and P57KIP2 immunohistochemistry using tissue microarray: Improving histopathological subtyping of hydatidiform mole.
    López CL; Figueira Gouvêa AL; Rodrigues FR; Braga A; Valente Machado MD; Lopes VS
    Placenta; 2020 Sep; 99():166-172. PubMed ID: 32810764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
    Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
    Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydatidiform Moles: Ancillary Techniques to Refine Diagnosis.
    Ronnett BM
    Arch Pathol Lab Med; 2018 Dec; 142(12):1485-1502. PubMed ID: 30500280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p53 expression in gestational trophoblastic disease.
    Lee YS
    Int J Gynecol Pathol; 1995 Apr; 14(2):119-24. PubMed ID: 8601523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [HLA and molar pregnancies (triploidies, hydatidiform moles and choriocarcinoma). Etiological and epidemiological study].
    Couillin P; Ravisé N; Afoutou JM; Chaïbi R; Azoulay M; Hors J; Oury JF; Boué J; Boué A
    Ann Genet; 1987; 30(4):197-208. PubMed ID: 3501264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trophoblastic disease: clinical pathology of hydatidiform moles.
    Szulman AE
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):443-56. PubMed ID: 3067170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic origin analysis of hydatidiform mole and non-molar abortion using the polymerase chain reaction method.
    Fujita N; Tamura S; Shimizu N; Nozawa S
    Acta Obstet Gynecol Scand; 1994 Oct; 73(9):719-25. PubMed ID: 7976249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.